跳至主要内容
临床试验/NCT02794766
NCT02794766已完成2 期

Inulin and Streptococcus Salivarius Reduce Halitosis Associated With Tongue Coating: A Randomized Clinical Trial

Universidade de Passo Fundo0 个研究点目标入组 45 人开始时间: 2014年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
45
主要终点
Halitosis Measured by Organoleptic Test

研究概览

简要总结

Halitosis associated with tongue coating results from the production of volatile sulfur compounds by bacterial action. The use of prebiotics and probiotics might be useful in treating such condition. The aim of this study was to evaluate the effect of the prebiotic inulin combined with the probiotic Streptococcus salivarius (SS) on halitosis by coating.

详细描述

Participants In this randomized, controlled, double-blind, parallel, phase II clinical trial, adult patients (≥18 years old) who complained of halitosis in the presence of tongue coating were invited to participate. They were identified with invitations in the form of posters distributed at the Dental School clinics, University of Passo Fundo (UPF), from August to November, 2015. The Dental School is located on the main campus of UPF,Passo Fundo, a city with >200.000 habitants. Oral halitosis was initially diagnosed by oral examination for tongue coating identification, followed by organoleptic test to confirm the halitosis. Total sample size was estimated in 45 participants, considering a difference of 80% in Halimeter reduction between treatments, for tests with α = 5% and power = 80%. Halitosis was defined by Halimeter values ≥ 75 ppb. All participants gave written consent before entering the study. The research protocol was approved by the local ethics committee (CAAE: 40334914.0.0000.5342).

Clinical examination Oral examination was performed by a trained dentist (CRM), identifying dental cavities, plaque, gingivitis, periodontal pockets and any dental prosthesis. Coating was described after visual inspection of the tongue and coating index was classified into 4 levels: 0 - no coating; 1 - thin coating on 1/3; 2 - thin coating on more than 1/3 or thick coating on only 1/3; 3 - thick coating on more than 1/3.5

Evaluation of halitosis After clinical examination, halitosis was quantified by organoleptic and Halimeter‡ tests. These were performed by a trained and calibrated examiner (CRM), with levels of agreement and reproducibility greater than 80% for organoleptic test and coating index, using test and retest comparisons with an expert judge (CKR). All patients were examined between 8 and 11 am. Patients were asked to avoid eating garlic, onion and other food condiments for two days before testing and avoid overeating margarine, milk, fry, sardines, salami, bologna, sausage, red meat, cheeses, foods with sulfur in the composition (cabbage, broccoli, cauliflower, egg), drinking alcohol and smoking, following protocols reported elsewhere.5, 13, 15 In the examination morning, patients should avoid using candies and gums, but were allowed to have breakfast and tooth brushing with water only. Once included in the study, patients were asked to avoid gums other than those provided in the trial.

Organoleptic test Patients at rest were instructed to hold air in the mouth while breathing through the nose for 1 min. They blow through mouth with the examiner (CRM) positioned 10 cm from the patient mouth. Patient breath was rated from 0 to 5, as follows: 0 - no smell, 1 - poor barely perceptible odour, 2 - slight stench, 3 - moderate smelly, 4 - strong stench, and 5 - severe stench.21 With the purpose of selecting patients, halitosis was considered present when this score was equal or higher than 1 in the presence of tongue coating.

Halimeter Patients had their breath objectively measured using a Halimeter, capable of measuring the VSC level. Halitosis is identified when the device registers ≥75 ppb.1, 22 The measurements were made by inserting a disposable straw into the patient mouth above the tongue. According to the manufacturer, the final result was obtained as the average of three measurements.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •adult patients with halitosis by tongue coating;
  • •participants must accept to participate in the study;
  • •tongue coating identified by oral examination;
  • •halitosis must be confirmed by the organoleptic test.

排除标准

  • •halitosis for other conditions, including periodontal diseases and non-oral conditions;
  • •use of antibiotics in the last 30 days;
  • •active smoking (>10 cigarettes/day);
  • •alcohol consumption (>2 drinks/day);
  • •report of pregnancy or breastfeeding;
  • •report of systemic diseases, including diabetes, kidney failure and hepatic cirrhosis.

研究组 & 干预措施

Inulin+SS

Experimental

Experimental treatment: A gum of inulin 1g plus Streptococcus salivarius 1 billion colony forming units (CFU) per oral each 12 hours for 10 days

干预措施: Inulin+SS (Drug)

S salivarius

Active Comparator

Active comparator: A gum of Streptococcus salivarius 1 billion CFU per oral each 12 hours for 10 days

干预措施: S salivarius (Drug)

Placebo

Placebo Comparator

Placebo 1 gum per oral each 12 hours, for 10 days

干预措施: Placebo (Drug)

结局指标

主要结局

Halitosis Measured by Organoleptic Test

时间窗: Halitosis measured by organoleptic test was performed before and 14 days after the treatments

Unabbreviated scale title: Organoleptic test Minimum: 0 Maximum: 5 Higher score means worse outcome.

Halitosis Measured by Halimeter

时间窗: Halitosis measured by halimeter test was performed before and 14 days after the treatments

Unabbreviated scale title: Halitosis measured by halimeter Minimum: 0 Maximum: 500 A score =\>75 ppb means halitosis.

Coating Index

时间窗: Coating index was evaluted before and 14 days after the treatments.

Unabbreviated scale title: Coating index (evaluated by a trained judge during oral examination) Minimum: 0 Maximum: 4 Higher score means worse outcome.

次要结局

  • Oral-health Related Quality of Life(Oral health impact profile -14 questionnaire was filled before and 14 days after the treatments)

研究者

发起方
Universidade de Passo Fundo
申办方类型
Other
责任方
Principal Investigator
主要研究者

Fernando Fornari

Professor

Universidade de Passo Fundo

相似试验